Oragenics and Inspirevax team up for Intranasal Covid Vaccine Candidate with Global License Agreement Read more
ImmunoGen Announces a Global, Multi-Target License and Option Agreement with Vertex for the Use of ImmunoGen’s ADC Technology in the Development of Novel Targeted Conditioning Agents Read more
BioNxt Signs Clinical Study Agreement and Commences Manufacture of Clinical Samples for Study of Transdermal Rotigotine Patch for Parkinson’s Disease Read more
Kevzara (sarilumab) Approved by FDA as First and Only Biologic Indicated for Patients with Polymyalgia Rheumatica Read more
Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment Read more
Tevard Biosciences and Vertex Partner to Create Breakthrough tRNA-Based Treatments for Duchenne Muscular Dystrophy Read more
Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS (Omaveloxolone), the First and Only Drug Indicated for Patients with Friedreich’s Ataxia Read more
Tempus Announces New Strategic Collaboration with Pfizer to Advance Oncology Therapeutic Development Read more
Rhythm Pharmaceuticals Announces Acquisition of Xinvento B.V. and Portfolio of Investigational Therapeutics Read more